USTEKINUMAB IN CROHN'S DISEASE MANAGEMENT: A BRAZILIAN OBSERVATIONAL STUDY.
Paula Cenira Senger de CastroDaniela Oliveira MagroRodrigo Bremer NonesThaísa Kowalski FurlanEron Fábio MirandaPaulo Gustavo KotzePublished in: Arquivos de gastroenterologia (2022)
UST therapy resulted in significant rates of remission and clinical response, as described in other real-world studies. Few patients had adverse events during treatment, showing its adequate safety profile.